Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI.
Raffaele PiccoloAttilio LeoneMarisa AvvedimentoFiorenzo SimonettiDomenico IppolitoDomenico AngellottiNicola VerdeLina ManziPlinio CirilloLuigi Di SerafinoGiuliana FortunatoAnna FranzoneGiovanni EspositoPublished in: European heart journal. Quality of care & clinical outcomes (2022)
In the setting of elective PCI, using hs-cTn instead of CK-MB resulted in a substantial increase in SCAI periprocedural MI events, which were not prognostically relevant in the absence of concurrent CK-MB elevations.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- protein kinase
- coronary artery bypass grafting
- atrial fibrillation
- heart failure
- left ventricular
- coronary artery bypass
- locally advanced
- squamous cell carcinoma
- radiation therapy
- rectal cancer